The continual spread of deadly pathogens coupled with the dwindling supply of antimicrobial treatments necessitates the development of effective prevention methods. However, the development of novel vaccines can be challenged by the incredible variability between microbial strains and the limitations associated with the vaccine manufacturing process.
At ATCC, we believe that it takes the combined efforts of dedicated scientists throughout the world to discover the treatments needed to keep humankind healthy and safe. That’s why we are committed to providing researchers with the virus-producing cell lines, pathogenic microbial strains, and purified pneumococcal polysaccharides needed to support vaccine research and development.
Together, we can work toward preventing and containing the world’s most devastating epidemics. Browse our resources below to discover how ATCC can support your vaccine research.
Vaccine development tools
Cell lines for enhanced virus production
ATCC used cutting-edge CRISPR/Cas9 gene-editing technology to develop STAT1 knockout and STAT1/BAX double knockout cell lines capable of producing high-titer viral stocks. Discover how these cell models can be used in your vaccine and gene therapeutic development projects.Learn more about these cell models
Residual host cell DNA testing
ATCC and USP formed a partnership to develop highly characterized and pure genomic DNA analytical reference materials for validating the performance of molecular assays designed to detect and measure residual host cell genomic DNA.Explore these analytical reference materials
293.STAT1 BAX KO
This STAT1 BAX double knockout HEK-293 cell line exhibits significant increased viral titer and enhanced virus production capability.Get the cells
Human adenovirus 5
Genome sequenced reference material for vaccine development and gene therapy.get started
For Influenza vaccine production, influenza propagation, and production of high-titer influenza stocks.order today
For viral vaccine production including virus propagation, production of high-titer viral stocks, and rescue of clinical viral isolates.buy today
Pneumococcal Polysaccaride Powder Type 19F
Isolated from Streptococcus pneumoniae for vaccine development.order today